重组人生长分化因子-15GDF-15蛋白
产品别名 |
生长分化因子-15,GDF-15,GDF-15蛋白 |
面向地区 |
|
分子别名(Synonym)
GDF15,GDF-15,MIC-1,MIC1,NAG-1,PDF,PLAB,PTGFB,NRG-1
内毒素(Endotoxin)
Less than 0.1 EU per μg by the LAL method.
无菌(Sterility)
The sterility testing was performed by membrane filtration method.
纯度(Purity)
>90% as determined by SDS-PAGE.
制剂(Formulation)
Lyophilized from 0.22 μm filtered solution in 30% ACN, 0.085% TFA with trehalose as protectant.
Contact us for customized product form or formulation.
重构方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存储(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.
背景(Background)
生长分化因子15(GDF-15),也称为巨噬细胞抑制细胞因子1(MIC-1)。单核细胞瘤细胞中MIC-1 mRNA的表达受到多种与活化相关的刺激物的上调,包括白介素1β、肿瘤坏死因子α(TNF-α)、白介素2和巨噬细胞集落刺激因子,而不是干扰素γ或脂多糖(LPS)。在正常和病理状态下,它在心肌细胞、脂肪细胞、巨噬细胞、内皮细胞和血管平滑肌细胞中高度表达。GDF-15在组织损伤和炎症状态期间增加,并与心脏代谢风险相关。GDF-15水平升高与心血管疾病相关,如肥大、心力衰竭、动脉粥样硬化、内皮功能障碍、肥胖、胰岛素抵抗、糖尿病和糖尿病中的慢性肾脏疾病。GDF-15水平升高与病情进展和预后相关。
查看全部介绍